GHK-Cu (glycine-histidine-lysine-copper) is a tripeptide that occurs naturally in human plasma, with concentrations declining significantly after age 60
Considering an increased thromboembolic risk among patients with diabetes mellitus 153,154,155,156,157 , we propose that physicians should consider prescribing antiplatelet or anticoagulating agents more actively in patients with diabetes mellitus to prevent thromboembolic events and their complications during the COVID-19 pandemic
They are FDA-approved for specific conditions, have controlled dosages, and cause minimal side effects
They must coordinate your care and adjust doses independently if side effects emerge
The more adipose (fat) tissue we carry around- especially in our mid sections- the more insulin resistance we develop
Its still important to eat well and exercise regularly to promote overall health and enhance the effects of the medication